Major Biotechnology Franchise Company Expands Rapidly Throughout the USA Amidst Mounting Healt... ( At a time wh...)

Major Biotechnology Franchise Company Expands Rapidly Throughout the USA Amidst Mounting Health Concerns

Date:11/10/2009

At a time when health is a major concern for many Americans and when the future of health is very uncertain, Easy Pha-max, an internationally recognized company, has opened its doors in the United States. Consumers now have more options to consider when making a decision about their health and what better time to have options than now. Easy Pha-max provides superior quality plant-based nutritional products that can address many health concerns without the worry of side-effects.

(PRWEB) November 10, 2009 -- Easy Pha-max is an internationally recognized company founded in 1996 that is headquartered in Malaysia. The company has an established presence in numerous countries around the world and now is growing in the United States. One of the distinct advantages of the company is that it utilizes a blue ocean concept which means that it serves as a catalyst for change as the company redefines the way business is done.

The products stand out for their efficacy, safety and unique formulation. The award- winning processes which are used to create the products cannot be duplicated. The company also manufactures its own products that have all won gold or silver medals in Geneva, Switzerland and Hong Kong for efficacy, quality standards as well as effectiveness.

The company's products serve to fight bacteria, illness and various degenerative diseases. The products also help to prevent many health issues that arise out of negligence of daily exercise routines, eating habits, stress levels, environment and lifestyle. However, the products should not be misconstrued as a "magical pill" that is the cure to all health problems.

Gurmit Singh, an Easy Pha-max franchise owner states that "people need to be educated about what our products can do for them and our m
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Novartis to Acquire Majority Stake in Hard to Treat Diseases (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million
2. Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People
3. Antibiotic Resistance Still a Major Public Health Threat
4. Life Insurance Firms Refusing to Insure Swine Flu Victims says major Canadian insurance broker
5. Celebrate A New Life, Christian Drug Rehab Program, Major Expansion in Southern California
6. Practice-changing cancer studies presented at major cancer meeting
7. Major research collaboration will improve British athletes performance on world stage
8. Evosys, a Major Player in the Oracle E-Business Suite Implementation, Support and Consultancy Services Domain, has Recently Been Awarded Oracles Certified Advantage Partner Status
9. Virginia Restaurants Urged to Go Completely Smoke-Free After Major Report Finds Smoke-Free Laws Prevent Heart Attacks
10. Consecos Four Major Offices Wrap Up Record-Breaking United Way Campaign
11. KEAP1 Keeps major cancer-promoting protein at bay

Post Your Comments:

Related Image:

Major Biotechnology Franchise Company Expands Rapidly Throughout the USA Amidst Mounting Health Concerns

(Date:12/5/2013)... Garden City, NY (PRWEB) December 05, 2013 ... and President of The KeLaHa Projects Foundation, as ... with this prestigious distinction. As the largest, most-recognized ... virtually every industry and profession, the National Association ... nearly 500,000 members and over 400 Local Chapters ...

(Date:12/5/2013)... 05, 2013 Who: Dr. Rodney Lemery, ... What: Webinar: " Evaluating and Investigating Drug Safety Signals ... BioPharm's Dr. Rodney Lemery, vice president of safety ... databases available to use during the evaluation and investigation ... the use of free and paid longitudinal healthcare databases ...

(Date:12/5/2013)... Dalvia Wellness Labs, a US-based company known for offering ... of its latest product – Dalvia L-Arginine Amino Acid ... company, this product has been specifically formulated to help people ... of the specific components of L-arginine – an amino acid ... vital body organs. , Studies have shown that L-arginine is ...

(Date:12/4/2013)... 2013 A new guideline released Thursday ... that most people with compromised immune systems are especially ... and other vaccinations. The guideline, entitled “Clinical Practice ... authored by Lorry G. Rubin, MD, director of the ... New York in New Hyde Park, NY, and professor ...

(Date:12/4/2013)... 2, 2013 Medical researchers point to developmental ... melatonin, as an explanation for why children get ... new study suggests that social ties, including relationships ... responsible for changing sleep patterns among adolescents. , ... important than biological development as predictors of teen ...

Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Keoma L. Hamer, Founder and President of The KeLaHa Projects Foundation, as VIP Woman of the Year 2 Health News:BioPharm Systems to Host Webinar on Evaluating and Investigating Drug Safety Signals with Public Databases 2 Health News:BioPharm Systems to Host Webinar on Evaluating and Investigating Drug Safety Signals with Public Databases 3 Health News:BioPharm Systems to Host Webinar on Evaluating and Investigating Drug Safety Signals with Public Databases 4 Health News:Announcing...Dalvia Wellness L-Arginine Amino Acid Complex Powder Launched 2 Health News:Announcing...Dalvia Wellness L-Arginine Amino Acid Complex Powder Launched 3 Health News:Cohen Pediatric Infectious Disease Chief Authors New Vaccination Guideline for Immunocompromised Patients 2 Health News:Social ties more important than biology when it comes to teen sleep problems 2 Health News:Social ties more important than biology when it comes to teen sleep problems 3

[0] National Association of Professional Women Announces Keoma L. Hamer, Founder and President of The KeLaHa Projects Foundation, as VIP Woman of the Year [0] BioPharm Systems to Host Webinar on Evaluating and Investigating Drug Safety Signals with Public Databases [0] Announcing...Dalvia Wellness L-Arginine Amino Acid Complex Powder Launched [0] Cohen Pediatric Infectious Disease Chief Authors New Vaccination Guideline for Immunocompromised Patients [0] Social ties more important than biology when it comes to teen sleep problems

... BASEL, Switzerland, Oct. 29 Roche (SWX: ROG.VX; RO.S),a ... it has extended its offer to acquire all of ... VMSI ),to 5:00 p.m., New York City time ... scheduled to expire at 5:00 p.m., New York City ...

... AIDS virus entered the United States via Haiti, probably arriving ... believed, according to new research. , After the virus, ... , "Our results show that the strain of virus ... around 1969. That is earlier than a lot of people ...

... or shorten the illness , MONDAY, Oct. 29 (HealthDay News) ... prevent pneumonia in elderly nursing home residents, a new study ... 617 people 65 and older in 33 nursing homes in ... blood zinc concentrations were about 50 percent less likely to ...

... produced responses in 40% of patients with Philadelphia, chromosome-positive chronic myeloid ... ... and availability in US means Novartis can offer physicians and ... EAST HANOVER, N.J., Oct. 29 Tasigna(R),(nilotinib) capsules have been approved in ...

... of Hepatitis C Treatment to Ongoing Oncology Program ... Ono Pharmaceutical,Co., Ltd. and Medarex, Inc. (Nasdaq: ... new drug application (IND) filed with the U.S. ... code of Ono,Pharmaceutical Co., Ltd.), a fully human ...

... Science,Corporation (Nasdaq: CSCX ), a global leader ... that it will present at the,18th Annual CIBC ... The,Company,s presentation is scheduled for Monday, November 5, ... and chief executive officer, will,review the Company,s business ...

Roche Extends Tender Offer for Ventana HIV's path out of Africa: Haiti, the US then the world Zinc Helps Elderly Ward Off Pneumonia Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody Cardiac Science to Present at the 18th Annual CIBC World Markets Healthcare Conference

(Date:12/5/2013)... 2013 Catabasis Pharmaceuticals, Inc. , today ... trial investigating the safety and efficacy of CAT-2003 ... triglyceride levels of 500 mg/dL or greater. CAT-2003 ... 3 fatty acid, eicosapentaenoic acid (EPA), employing Catabasis, ... second Phase 2 trial of CAT-2003, patients with ...

(Date:12/5/2013)... 5, 2013 Eli Lilly and Company (NYSE: ... from three studies of edivoxetine did not meet ... depression after eight weeks of treatment. When added ... did not separate from placebo on the Montgomery-Asberg ... placebo-controlled Phase III studies (LNBM, LNBQ and LNBR). ...

(Date:12/5/2013)... Ambit Biosciences (Nasdaq: AMBI ), a biopharmaceutical ... unmet needs in oncology, autoimmune and inflammatory disease, today ... Annual Healthcare Conference to be held at the ... , December 10-11, 2013. Michael ... the Company and its lead drug candidate, Quizartinib, at ...

Breaking Medicine Technology:Catabasis Initiates Phase 2 Trial of CAT-2003 in Patients with Severe Hypertriglyceridemia 2 Catabasis Initiates Phase 2 Trial of CAT-2003 in Patients with Severe Hypertriglyceridemia 3 Lilly Announces Edivoxetine Did Not Meet Primary Endpoint of Phase III Clinical Studies as Add-On Therapy for Major Depressive Disorder 2 Lilly Announces Edivoxetine Did Not Meet Primary Endpoint of Phase III Clinical Studies as Add-On Therapy for Major Depressive Disorder 3 Ambit Announces Participation At Oppenheimer 24th Annual Healthcare Conference 2

[0] Catabasis Initiates Phase 2 Trial of CAT-2003 in Patients with Severe Hypertriglyceridemia [0] Lilly Announces Edivoxetine Did Not Meet Primary Endpoint of Phase III Clinical Studies as Add-On Therapy for Major Depressive Disorder [0] Ambit Announces Participation At Oppenheimer 24th Annual Healthcare Conference

... SAN CARLOS, Calif., June 23, 2011 PharmacoFore, ... abuse-resistant prescription drugs, today announced positive results from ... its hydromorphone (HM) Bio-Activated Molecular Delivery™ (Bio-MD™) product ... will present at the 2011 BIO Business Forum ...

... Today,s U.S. Supreme Court decision in ... safety, giving generic drug companies legal immunity when they ignore ... This decision eliminates any incentive for generic manufacturers to ensure ... drugs, potential dangers. This decision also means that ...

Cached Medicine Technology:PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was 2 PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was 3 PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was 4 Generic Drug Decision Disastrous to Patient Safety 2

PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was Generic Drug Decision Disastrous to Patient Safety

ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.15% is medication in the form of an eye drop that is used to lower the pressure inside your eye(s), also referred to as intraocular pressu...

... ophthalmic solution is a prescription eye ... you to use after your cataract ... and may cause them to become ... of inflammation include redness and swelling. ...

Store and manage many ECG data from ECG-9020, ECG-9130 or ECG-9320 on the PC. You can search, view, compare, print, and edit analysis results of ECG, and send it to other physicians by e- mail....

Medicine Products:

ALPHAGAN® P 15 mL ALPHAGAN® P 5 mL ACULAR® 10 mL ECG Viewer